United Therapeutics Corp. (UTHR)
558.05
-1.05
(-0.19%)
USD |
NASDAQ |
Nov 20, 10:21
United Therapeutics Free Cash Flow : 863.80M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 863.80M |
| June 30, 2026 | 1.084B |
| March 31, 2026 | 1.011B |
| December 31, 2025 | 1.035B |
| September 30, 2025 | 1.116B |
| June 30, 2025 | 1.068B |
| March 31, 2025 | 1.126B |
| December 31, 2024 | 1.078B |
| September 30, 2024 | 898.10M |
| June 30, 2024 | 880.60M |
| March 31, 2024 | 755.10M |
| December 31, 2023 | 747.60M |
| September 30, 2023 | 754.10M |
| June 30, 2023 | 663.40M |
| March 31, 2023 | 711.80M |
| December 31, 2022 | 656.20M |
| September 30, 2022 | 679.00M |
| June 30, 2022 | 651.50M |
| March 31, 2022 | 673.40M |
| December 31, 2021 | 477.40M |
| September 30, 2021 | 485.60M |
| June 30, 2021 | 558.40M |
| March 31, 2021 | 572.30M |
| December 31, 2020 | 694.70M |
| September 30, 2020 | 660.30M |
| Date | Value |
|---|---|
| June 30, 2020 | 597.00M |
| March 31, 2020 | 563.80M |
| December 31, 2019 | -290.30M |
| September 30, 2019 | -301.50M |
| June 30, 2019 | -310.30M |
| March 31, 2019 | -296.60M |
| December 31, 2018 | 594.00M |
| September 30, 2018 | 413.80M |
| June 30, 2018 | 487.30M |
| March 31, 2018 | 410.80M |
| December 31, 2017 | 387.90M |
| September 30, 2017 | 650.20M |
| June 30, 2017 | 633.30M |
| March 31, 2017 | 698.80M |
| December 31, 2016 | 600.40M |
| September 30, 2016 | 445.68M |
| June 30, 2016 | 422.95M |
| March 31, 2016 | 344.80M |
| December 31, 2015 | 332.97M |
| September 30, 2015 | 427.31M |
| June 30, 2015 | 425.33M |
| March 31, 2015 | 320.87M |
| December 31, 2014 | 307.82M |
| September 30, 2014 | 310.50M |
| June 30, 2014 | 245.50M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Liquidia Corp. | 291.15M |
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Exelixis, Inc. | 1.161B |
| Gilead Sciences, Inc. | 13.78B |
| Insmed, Inc. | -657.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 306.50M |
| Cash from Investing (Quarterly) | -510.60M |
| Cash from Financing (Quarterly) | -410.20M |
| Free Cash Flow Per Share (Quarterly) | 2.777 |
| Free Cash Flow to Equity (Quarterly) | 125.80M |
| Free Cash Flow to Firm (Quarterly) | 127.81M |
| Free Cash Flow Yield | 3.65% |